OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 82 filers reported holding OVID THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $695,000 | -48.9% | 121,116 | -34.4% | 0.16% | -45.2% |
| Q2 2020 | $1,361,000 | +147.5% | 184,728 | 0.0% | 0.30% | +76.0% |
| Q1 2020 | $550,000 | -53.5% | 184,728 | -35.2% | 0.17% | -34.2% |
| Q4 2019 | $1,183,000 | +77.1% | 285,065 | +38.3% | 0.26% | +46.9% |
| Q3 2019 | $668,000 | – | 206,118 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
| BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
| COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
| ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
| Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
| Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
| Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
| Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
| Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |